1
|
World Health Organisation (WHO): WHO
characterizes COVID-19 as a pandemic. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen.
Accessed March 11, 2020.
|
2
|
Tsamakis K, Rizos E, Manolis AJ, Chaidou
S, Kympouropoulos S, Spartalis E, Spandidos DA, Tsiptsios D and
Triantafyllis AS: COVID-19 pandemic and its impact on mental health
of healthcare professionals. Exp Ther Med. 19:3451–3453.
2020.PubMed/NCBI View Article : Google Scholar
|
3
|
French Hospital Federation (FHF): COVID-19
et Cancers Solides: Recommandations. FHF, Paris, 2020. https://www.fhf.fr/
Offre-de-soins-Qualite/
Organisation-de-l-offre-de-soins/COVID-19-et-Cancers-Solides-Recommandations |
4
|
Simcock R, Thomas TV, Estes C, Filippi AR,
Katz MA, Pereira IJ and Saeed H: COVID-19: Global radiation
oncology's targeted response for pandemic preparedness. Clin Transl
Radiat Oncol. 22:55–68. 2020.PubMed/NCBI View Article : Google Scholar
|
5
|
Coles CE, Aristei C, Bliss J, Boersma L,
Brunt AM, Chatterjee S, Hanna G, Jagsi R, Person OK, Kirby A, et
al: International guidelines on radiation therapy for breast cancer
during the COVID-19 pandemic. Clin Oncol. 32:279–281.
2020.PubMed/NCBI View Article : Google Scholar
|
6
|
Filippi AR, Russi E, Magrini SM and Corvò
R: COVID-19 outbreak in northern Italy: first practical indications
for Radiotherapy Departments. Int J Radiat Oncol: doi: https://doi.org/10.1016/j.ijrobp.2020.03.007.
|
7
|
European Society of Surgical Oncology
(ESSO): ESSO Statement on COVID-19. ESSO, Brussels, 2020.
https://www.essoweb.org/news/esso-statement-covid-19/.
Accessed May 29, 2020.
|
8
|
Cancer Research UK: Coronavirus (COVID-19)
and cancer treatment. https://www.cancerresearchuk.org/about-cancer/cancer-in-general/
coronavirus/cancer-treatment |
9
|
Burger R: A promising approach to
identifying health system discrimination and bias. Lancet Glob
Health. 7:E546–E547. 2019.PubMed/NCBI View Article : Google Scholar
|
10
|
Committee on Guidance for Establishing
Crisis Standards of Care for Use in Disaster Situations; Institute
of Medicine: Legal Issues in Emergencies. In: Crisis Standards of
Care: A Systems Framework for Catastrophic Disaster Response.
National Academies Press (US), Washington, DC, 2012.
|
11
|
Vrinten C, van Jaarsveld CHM, Waller J,
von Wagner C and Wardle J: The structure and demographic correlates
of cancer fear. BMC Cancer. 14(597)2014.PubMed/NCBI View Article : Google Scholar
|
12
|
Goold SD and Lipkin M: The doctor-patient
relationship. J Gen Intern Med. 14:S26–S33. 1999.PubMed/NCBI View Article : Google Scholar
|
13
|
Brody H: The Physician - patient
relationship. In: Medical Ethics. Veatch RM (ed). 2nd edition.
Jones and Bartlett Publishers. pp75–102. 1997.
|
14
|
Spiegel D, Bloom JR, Kraemer H and
Gottheil E: Psychological support for cancer patients. Lancet.
2(1447)1989.PubMed/NCBI View Article : Google Scholar
|
15
|
Kofinas S: The priest's ministry at the
hospital. In: Introduction to Pastoral Ministry in Health.
Therapeian Prosagontes, Athens. pp171–203. 2011.
|
16
|
Eftichiadis Ch: Institution of the
Hospital Pastor. Official Website of the Church of Greece, 1999.
http://ecclesia.gr/greek/holysynod/commitees/pastoral/nosokomeio_efimerios.html.
|
17
|
Balboni TA, Vanderwerker LC, Block SD,
Paulk ME, Lathan CS, Peteet JR and Prigerson HG: Religiousness and
spiritual support among advanced cancer patients and associations
with end-of-life treatment preferences and quality of life. J Clin
Oncol. 25:555–560. 2007.PubMed/NCBI View Article : Google Scholar
|
18
|
Balboni T, Balboni M, Paulk ME, Phelps A,
Wright A, Peteet J, Block S, Lathan C, Vanderweele T and Prigerson
H: Support of cancer patients' spiritual needs and associations
with medical care costs at the end of life. Cancer. 117:5383–5391.
2011.PubMed/NCBI View Article : Google Scholar
|
19
|
Ford EC and Evans SB: Incident learning in
radiation oncology: A review. Med Phys. 45:e100–e119.
2018.PubMed/NCBI View
Article : Google Scholar
|
20
|
International Atomic Energy Agency (IAEA):
Radiotherapy in Cancer Care: Facing the Global Challenge. IAEA,
Vienna, 2017. https://www.iaea.org/publications/10627/radiotherapy-in-cancer-care-facing-the-global-challenge.
|
21
|
Agence fédérale de Contrôle Nucleaire
(AFCN): Arrêté royal relatif aux expositions médicales et aux
expositions à des fins d'imagerie non médicale avec des équipements
radiologiques médicaux. https://afcn.fgov.be/fr/system/files/20200220-publicatie-kb-med.pdf.
Accessed February 13, 2020.
|
22
|
Federaal Agentschap voor Nucleaire
Controle (FANC): Règlement technique fixant le barème d'attribution
pour les activités de formation continue de l'expert agréé en
radiophysique médicale. https://fanc.fgov.be/nl/system/files/2020-03-10-permanente-vorming-msf.pdf.
Accessed March 3, 2020.
|
23
|
Agence fédérale de Contrôle Nucleaire
(AFCN): Prolongation automatique de l'autorisation d'utilisation
des rayons X à des fins d'imagerie médicale et exemption de
formation continue pour l'année 2020. AFCN, Brussels, 2020.
https://www.gbs-vbs.org/fileadmin/user_upload/e-specialist/2020/EDR_Covid_19_2020_FR_signe.pdf.
Accessed April 7, 2020.
|
24
|
Agence Nationale de Sécurité du Médicament
et des Produits de Santé (ANSM): Contrôle qualité des dispositifs
médicaux. ANSM, Saint-Denis Cedex, 2020. https://www.ansm.sante.fr/Activites/Maintenance-et-controle-qualite-des-dispositifs-medicaux/Controle-qualite-des-dispositifs-medicaux/(offset)/0.
Accessed April 24, 2020.
|
25
|
Société Française de Physique Médicale
(SFRO): Epidémie de COVID-19: Recommandations à l'usage des
professionnels de l'Oncologie Radiothérapie. https://www.sfpm.fr/sites/www.sfpm.fr/files/Bibliotheque/Travaux_en_cours/Conseil_administration/recommandations_covid_19_sfro_v2.pdf.
Accessed March 19, 2020.
|
26
|
Bartelink H, Maingon P, Poortmans P,
Weltens C, Fourquet A, Jager J, Schinagl D, Oei B, Rodenhuis C,
Horiot JC, et al: European Organisation for Research and Treatment
of Cancer Radiation Oncology and Breast Cancer Groups: Whole-breast
irradiation with or without a boost for patients treated with
breast-conserving surgery for early breast cancer: 20-year
follow-up of a randomised phase 3 trial. Lancet Oncol. 16:47–56.
2015.
|